TrialLeukemia2023

Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.

Kate Manos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.